Morgan Lewis has been named a finalist in the Innovative Lawyers in Disputes and Crisis Management category for the Financial Times’ Innovative Lawyers Awards Europe 2025.
The recognition relates to the appeal led by Frances Murphy and Leonidas Theodosiou for Focus Pharma/Advanz Pharma against a CMA decision finding that three pharmaceutical companies were involved in market sharing with respect to anti-nausea medicine prochlorperazine and claims by the CMA for Competition Director Disqualification Orders. The appeal succeeded in securing a rare judgment by the Competition Appeal Tribunal which set aside the CMA’s decision in full, rejected the CMA’s claims for director disqualification orders and explicitly exonerated the directors.
Winners will be announced at an awards dinner in London on September 18.
See the full Financial Times shortlist>>
Subscription may be required.